US Map / Ohio
State OH

Clinical Trials in Ohio

Ohio is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Ohio and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 522 actively recruiting studies with Ohio sites out of 522 registered in total. The busiest research areas in Ohio are Prostate Cancer, Breast Cancer, Ovarian Cancer. Leading sponsors running trials in the state include Ohio State University, Children's Hospital Medical Center, Cincinnati, National Cancer Institute (NCI). By stage, Ohio trials break down as Phase 1 (98), Phase 2 (162), Phase 3 (125), Phase 4 (23).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
522
Recruiting Now
522
← Back to US Map
Top Conditions in Ohio
Prostate Cancer (9)Breast Cancer (9)Ovarian Cancer (8)Endometrial Cancer (7)Acute Myeloid Leukemia (6)Solid Tumor (6)Pancreatic Cancer (5)Heart Failure (5)Multiple Myeloma (5)Colorectal Cancer (5)Advanced Solid Tumor (5)Stroke (5)

Frequently Asked Questions — Clinical Trials in Ohio

How many clinical trials are currently recruiting in Ohio?
ClinicalMetric currently tracks 522 actively recruiting clinical trials with at least one location in Ohio. The total number of registered studies—including active but not currently enrolling trials—is 522. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Ohio?
Ohio hosts clinical trials across a broad range of medical conditions, including Prostate Cancer, Breast Cancer, Ovarian Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Ohio serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Ohio?
To join a clinical trial in Ohio, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Ohio maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Ohio

NCT06027996 N/A
Recruiting
Melodi Matrix™ in Breast Reconstruction
Condition
Breast Reconstruction
Enrollment
702 pts
Location
United States
Sponsor
Melodi Health, Inc.
View Trial →
NCT07517588 N/A
Recruiting
EFS of Posterior Leaflet Replacement to Reduce Mitral Regurgitation (United Stat...
Condition
Mitral Regurgitation
Enrollment
15 pts
Location
United States
Sponsor
Polares Medical SA
View Trial →
NCT06950385 Phase 3
Recruiting
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
Condition
Familial Adenomatous Polyposis (FAP)
Enrollment
168 pts
Location
United States, Denmark, Germany
Sponsor
Rapamycin Holdings Inc.
View Trial →
NCT06161974 Phase 2
Recruiting
Study of Olutasidenib and Temozolomide in HGG
Condition
High Grade Glioma
Enrollment
60 pts
Location
United States, Australia, Canada
Sponsor
Rigel Pharmaceuticals
View Trial →
NCT06396078 Phase 4
Recruiting
Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT...
Condition
Preterm Premature Rupture of Membrane
Enrollment
56 pts
Location
United States
Sponsor
Ohio State University
View Trial →
NCT05200923 N/A
Recruiting
Pelvic Health Electrically Evoked Recording (PEER) 2 Study
Condition
Overactive Bladder
Enrollment
300 pts
Location
United States
Sponsor
MedtronicNeuro
View Trial →
NCT06678659 Phase 1, Phase 2
Recruiting
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Meta...
Condition
Unresectable
Enrollment
170 pts
Location
United States, Canada
Sponsor
Recursion Pharmaceuticals Inc.
View Trial →
NCT06562543 Phase 4
Recruiting
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populati...
Condition
Colorectal Cancer
Enrollment
78 pts
Location
United States, Puerto Rico
Sponsor
Takeda
View Trial →
NCT04634240 N/A
Recruiting
Staged Complete Revascularization for Coronary Artery Disease vs Medical Managem...
Condition
Aortic Stenosis
Enrollment
4,000 pts
Location
United States, Canada
Sponsor
University of British Columbia
View Trial →
NCT07616128 Phase 2
Recruiting
Study of EVO756 in Adults With Migraine
Condition
Migraine
Enrollment
330 pts
Location
United States, Australia, Canada
Sponsor
Evommune, Inc.
View Trial →
NCT07813247 N/A
Recruiting
Robotic Adrenalectomy With Versus Without Indocyanine Green Fluorescence Imaging
Condition
Adrenalectomy
Enrollment
55 pts
Location
United States
Sponsor
The Cleveland Clinic
View Trial →
NCT06119685 Phase 1, Phase 2
Recruiting
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients...
Condition
NHL
Enrollment
128 pts
Location
United States
Sponsor
Indapta Therapeutics, INC.
View Trial →
NCT06023589 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Plac...
Condition
Asthma
Enrollment
231 pts
Location
United States, Argentina, Brazil
Sponsor
AstraZeneca
View Trial →
NCT06706674 Phase 3
Recruiting
Multicenter Study of Lumateperone for the Treatment of Irritability Associated W...
Condition
Irritability Associated With Autism Spectrum Disorder
Enrollment
160 pts
Location
United States
Sponsor
Intra-Cellular Therapies, Inc.
View Trial →
NCT06229210 Phase 3
Recruiting
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizop...
Condition
Schizophrenia
Enrollment
300 pts
Location
United States, Colombia, Serbia
Sponsor
Intra-Cellular Therapies, Inc.
View Trial →
NCT03146676 N/A
Recruiting
The Ohio State University Dermatology Biorepository
Condition
Hidradenitis Suppurativa
Enrollment
175 pts
Location
United States
Sponsor
Ohio State University
View Trial →
NCT00623389 N/A
Recruiting
Evaluation of an Advanced Lower Extremity Neuroprostheses
Condition
Spinal Cord Injuries
Enrollment
10 pts
Location
United States
Sponsor
Case Western Reserve Universit
View Trial →
NCT07614984 Phase 2
Recruiting
A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein...
Condition
Lipoprotein(a)
Enrollment
750 pts
Location
United States, Canada, Colombia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07182149 Phase 1
Recruiting
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic R...
Condition
HNSCC
Enrollment
150 pts
Location
United States
Sponsor
Normunity AccelCo, Inc.
View Trial →
NCT07489885 Phase 2
Recruiting
A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoria...
Condition
Psoriasis
Enrollment
75 pts
Location
United States
Sponsor
InventisBio Co., Ltd
View Trial →
NCT07820085 Phase 2, Phase 3
Recruiting
A Study to Investigate PORT-77 Oral Dosing Compared With Placebo in Participants...
Condition
Erythropoietic Protoporphyria (EPP)
Enrollment
225 pts
Location
United States
Sponsor
Portal Therapeutics, Inc.
View Trial →
NCT06126276 Phase 2
Recruiting
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Tar...
Condition
Malignant Female Reproductive System Neoplasm
Enrollment
70 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT04256317 Phase 2, Phase 3
Recruiting
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplas...
Condition
Myelodysplastic Syndromes
Enrollment
316 pts
Location
United States, Canada, Czechia
Sponsor
Taiho Oncology, Inc.
View Trial →
NCT03932162 EARLY_Phase 1
Recruiting
Gene Expression Changes In Young and Geriatric Skin
Condition
UVB Phototherapy Burn
Enrollment
24 pts
Location
United States
Sponsor
Wright State University
View Trial →
NCT06996782 Phase 1, Phase 2
Recruiting
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
Condition
Advanced or Metastatic Non-small Cell Lung Cancer
Enrollment
152 pts
Location
United States, Belgium, Brazil
Sponsor
AstraZeneca
View Trial →
Page 9 of 21 — 522 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology